December 10, 2015 — Dilon Diagnostics and GE Healthcare announced the signing of an agreement for Dilon to distribute GE's Discovery NM750b Molecular Breast Imaging system in select geographies across the globe.
The Discovery NM750b breast imaging system, designed to provide significant enhancement in lesion detectability, offers clinicians a tool for imaging of a broad range of patients, including those with dense breasts who may be at higher risk for breast cancer. Functional imaging to see early changes is a key factor in early detection in breast cancer.
For more information: www.dilon.com, www.gehealthcare.com
October 30, 2026 
